Lasix | Yes | 3 (60.0%) | 13 (76.5%) | 0.585 (F) |
HCTZ | Yes | 1 (20.0%) | 1 (5.9%) | 0.411 (F) |
Coumadin | Yes | 1 (20.0%) | 1 (5.9%) | 0.411 (F) |
Amiodarone | Yes | 2 (40.0%) | 0 (0.0%) | 0.043 (F)* |
Contrast Agent | Yes | 0 (0.0%) | 3 (18.8%) | 0.549 (F) |
Age | 63.2 ± 14.6 | 63.3 ± 13.1 | 0.989 (T) | |
BMI | 34.6 ± 9.9 | 31.1 ± 8.8 | 0.450 (T) | |
LVEF | 32.0 ± 2.7 | 21.5 ± 6.4 | 0.002 (T)* | |
VS SBP | 112.0 ± 13.5 | 119.2 ± 16.7 | 0.387 (T) | |
VS DBP | 71.4 ± 5.8 | 71.9 ± 11.5 | 0.930 (T) | |
VS Resp | 20.6 ± 5.4 | 18.4 ± 1.5 | 0.597 (W) | |
VSO2 Sat | 92.6 ± 5.0 | 95.3 ± 2.7 | 0.125 (T) | |
BSA | 2.3 ± 0.4 | 2.0 ± 0.4 | 0.232 (T) | |
Echo LV Mass | 162.6 ± 26.5 | 207.0 ± 33.4 | 0.015 (T)* | |
Echo LVM BSA | 73.6 ± 16.1 | 105.2 ± 23.3 | 0.012 (T)* | |
Echo LV EDV | 164.5 ± 43.2 | 203.8 ± 50.2 | 0.136 (T) | |
Echo LVEF | 43.0 ± 7.3 | 34.0 ± 4.7 | 0.005 (T)* | |
MPI LVEF | 38.0 ± 6.3 | 25.1 ± 7.1 | 0.002 (T)* | |
LVEF Follow-up minus Baseline | −1.0 ± 13.2 | 9.1 ± 15.3 | 0.287 (T) | |
EDV Follow-up minus Baseline | −0.1 ± 1.6 | −0.5 ± 0.9 | 0.566 (T) | |
ESV Follow-up minus Baseline | 0.8 ± 2.2 | −0.5 ± 0.9 | 0.216 (T) |